Cancer cells exhibit distinct metabolic profiles that support their growth and survival. These metabolic adaptations, such as aerobic glycolysis (the Warburg effect), are crucial for cancer cell proliferation and are driven by oncogenic signaling pathways. The Warburg effect, characterized by increased glycolysis and lactate production, provides cancer cells with energy and biosynthetic precursors while managing oxidative stress. This metabolic shift is essential for tumor growth and is influenced by factors like the PI3K/Akt/mTOR pathway, which promotes glycolysis and anabolic processes. However, cancer cells also face challenges from reactive oxygen species (ROS), which are managed through antioxidant mechanisms like NADPH production and the pentose phosphate pathway (PPP). Mutations in genes such as IDH1 and IDH2 lead to the production of 2-hydroxyglutarate (2-HG), which inhibits key enzymes and contributes to cancer progression. Additionally, metabolic flexibility allows cancer cells to utilize alternative energy sources like fatty acids and amino acids under stress conditions. The interplay between metabolic pathways, signaling molecules, and tumor suppressors like p53 and FOXO is critical for cancer cell survival and transformation. Understanding these metabolic adaptations provides insights into potential therapeutic targets for cancer treatment.Cancer cells exhibit distinct metabolic profiles that support their growth and survival. These metabolic adaptations, such as aerobic glycolysis (the Warburg effect), are crucial for cancer cell proliferation and are driven by oncogenic signaling pathways. The Warburg effect, characterized by increased glycolysis and lactate production, provides cancer cells with energy and biosynthetic precursors while managing oxidative stress. This metabolic shift is essential for tumor growth and is influenced by factors like the PI3K/Akt/mTOR pathway, which promotes glycolysis and anabolic processes. However, cancer cells also face challenges from reactive oxygen species (ROS), which are managed through antioxidant mechanisms like NADPH production and the pentose phosphate pathway (PPP). Mutations in genes such as IDH1 and IDH2 lead to the production of 2-hydroxyglutarate (2-HG), which inhibits key enzymes and contributes to cancer progression. Additionally, metabolic flexibility allows cancer cells to utilize alternative energy sources like fatty acids and amino acids under stress conditions. The interplay between metabolic pathways, signaling molecules, and tumor suppressors like p53 and FOXO is critical for cancer cell survival and transformation. Understanding these metabolic adaptations provides insights into potential therapeutic targets for cancer treatment.